Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Junta Imai"'
Autor:
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1211-1219 (2024)
ABSTRACT Aims/Introduction Insulin resistance syndrome and lipoatrophic diabetes are rare conditions characterized by the development of treatment‐refractory diabetes with severe insulin resistance. We recently conducted a 24 week, multicenter, sin
Externí odkaz:
https://doaj.org/article/d60e2f3c3183423c9437d2a067c99250
Autor:
Junta Imai
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1171-1173 (2024)
Externí odkaz:
https://doaj.org/article/ad23b7b6722b4e199563b81603aad5ad
Autor:
Masato Kohata, Shinjiro Kodama, Nobuhiro Yaoita, Shinichiro Hosaka, Kei Takahashi, Keizo Kaneko, Junta Imai, Satoshi Yasuda, Hideki Katagiri
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 8, Pp 1005-1008 (2023)
Abstract A 25‐year‐old man was diagnosed with diabetic ketoacidosis (DKA) at the onset of fulminant type 1 diabetes. After acute‐phase DKA treatment including placement of a central venous catheter, a massive deep vein thrombosis (DVT) and pulm
Externí odkaz:
https://doaj.org/article/260cb9d808154ca5ac6fd01a01bb6ba1
Autor:
Hiroto Sugawara, Junta Imai, Junpei Yamamoto, Tomohito Izumi, Yohei Kawana, Akira Endo, Masato Kohata, Junro Seike, Haremaru Kubo, Hiroshi Komamura, Yuichiro Munakata, Yoichiro Asai, Shinichiro Hosaka, Shojiro Sawada, Shinjiro Kodama, Kei Takahashi, Keizo Kaneko, Hideki Katagiri
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Cell proliferation processes play pivotal roles in timely adaptation to many biological situations. Herein, we establish a highly sensitive and simple strategy by which time-series showing the proliferation of a targeted cell type can be qua
Externí odkaz:
https://doaj.org/article/a64743050e8849b4a576987533ebe56b
Autor:
Haremaru Kubo, Shojiro Sawada, Michihiro Satoh, Yoichiro Asai, Shinjiro Kodama, Toshihiro Sato, Seitaro Tomiyama, Junro Seike, Kei Takahashi, Keizo Kaneko, Junta Imai, Hideki Katagiri
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Insulin like growth factor-1 (IGF-1) plays important roles in metabolic functions, especially in adulthood. Additionally, obese subjects are reportedly predisposed to having low absolute IGF-1 levels. However, the prevalence and clinical cha
Externí odkaz:
https://doaj.org/article/d316480ed876402eae1d68b175b6139b
Autor:
Masato Kohata, Junta Imai, Tomohito Izumi, Junpei Yamamoto, Yohei Kawana, Akira Endo, Hiroto Sugawara, Junro Seike, Haremaru Kubo, Hiroshi Komamura, Toshihiro Sato, Shinichiro Hosaka, Yuichiro Munakata, Yoichiro Asai, Shinjiro Kodama, Kei Takahashi, Keizo Kaneko, Hideki Katagiri
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 10, Pp 1666-1676 (2022)
ABSTRACT Aims/Introduction Whether basal β‐cell proliferation during adulthood is involved in maintaining sufficient β‐cell mass, and if so, the molecular mechanism(s) underlying basal β‐cell proliferation remain unclear. FoxM1 is a critical
Externí odkaz:
https://doaj.org/article/d05dbe7f5379427983242b019fd55228
Autor:
Junta Imai
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 10, Pp 1646-1648 (2022)
Externí odkaz:
https://doaj.org/article/3c1842f5b7874fee803ae4366ad99ae1
Autor:
Satoko Hatayama, Shinjiro Kodama, Yohei Kawana, Sonoko Otake, Daiki Sato, Takahiro Horiuchi, Kei Takahashi, Keizo Kaneko, Junta Imai, Hideki Katagiri
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 8, Pp 1458-1460 (2022)
ABSTRACT Various immune‐related adverse events (irAEs), including fulminant type 1 diabetes (FT1D), are known to be associated with immune checkpoint inhibitors (ICIs). We experienced two lung adenocarcinoma cases who developed fulminant type 1 dia
Externí odkaz:
https://doaj.org/article/9665d9e385de4af5b054339ed518978f
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 7, Pp 1518-1520 (2022)
Recently, along with increasing use of immune checkpoint inhibitors such as nivolumab, the incidence of immune-related adverse events, including type 1 diabetes mellitus, has become a serious problem. We report a patient who had immune checkpoint inh
Externí odkaz:
https://doaj.org/article/237e8b5c89944ea5ae0771cb4b0213c8
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 3, Pp 498-499 (2023)
Externí odkaz:
https://doaj.org/article/0c37f41d0b39421a9757e5bcaf1a61b1